All Stories

  1. Novel therapeutics and future directions for refractory immune thrombocytopenia

    Article • British Journal of Haematology, September 2023, Wiley

    Dr Ellis J Neufeld

  2. The cost-effectiveness of gene therapy for severe hemophilia B: a microsimulation study from the United States perspective

    Article • Blood, November 2021, American Society of Hematology

    Dr Ellis J Neufeld

  3. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study

    Article • Thrombosis and Haemostasis, February 2021, Thieme Publishing Group

    Dr Ellis J Neufeld

  4. Comorbidities and complications in adults with pyruvate kinase deficiency

    Article • European Journal Of Haematology, January 2021, Wiley

    Dr Ellis J Neufeld

  5. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

    Article • New England Journal of Medicine, March 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Ellis J Neufeld

  6. Bioengineering hemophilia A–specific microvascular grafts for delivery of full-length factor VIII into the bloodstream

    Article • Blood Advances, December 2019, American Society of Hematology

    Dr Ellis J Neufeld

  7. Inhibitor Development with Simoctocog Alfa in Previously Untreated Patients with Severe Haemophilia a: Final Results of the Nuprotect Study

    Article • Blood, November 2019, American Society of Hematology

    Dr Ellis J Neufeld

  8. Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes

    Article • American Journal of Hematology, April 2019, Wiley

    Dr Ellis J Neufeld

  9. Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia

    Article • Haemophilia, April 2019, Wiley

    Dr Ellis J Neufeld

  10. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

    Article • Haematologica, September 2018, Ferrata Storti Foundation (Haematologica)

    Dr Ellis J Neufeld

  11. Recombinant activated factor VII in approved indications: Update on safety

    Article • Haemophilia, July 2018, Wiley

    Soraya Benchikh El Fegoun, Dr Ellis J Neufeld

  12. Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States

    Article • Journal of Medical Economics, June 2018, Taylor & Francis

    Dr Ellis J Neufeld

  13. Focusing in on use of pharmacokinetic profiles in routine hemophilia care

    Article • Research and Practice in Thrombosis and Haemostasis, May 2018, Wiley

    Professor Alfonso Iorio, Joanna Davis, Dr Ellis J Neufeld

  14. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations

    Article • Research and Practice in Thrombosis and Haemostasis, May 2018, Wiley

    Massimo Morfini, Professor Alfonso Iorio, Dr Ellis J Neufeld

  15. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study

    Article • Blood, May 2018, American Society of Hematology

    Dr Ellis J Neufeld

  16. Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia

    Article • American Journal of Hematology, October 2017, Wiley

    Dr Ellis J Neufeld

  17. Risk of post-procedural bleeding in children on intravenous fish oil

    Article • The American Journal of Surgery, October 2017, Elsevier

    Dr Ellis J Neufeld

  18. Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study

    Article • Haemophilia, August 2017, Wiley

    Sunil Lohade, Dr Ellis J Neufeld

  19. Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices

    Article • Haemophilia, July 2017, Wiley

    Dr Ellis J Neufeld

  20. Recombinant porcine factor VIII for high‐risk surgery in paediatric congenital haemophilia A with high‐titre inhibitor

    Article • Haemophilia, January 2017, Wiley

    Dr Ellis J Neufeld

  21. Ringed sideroblasts in β‐thalassemia

    Article • Pediatric Blood & Cancer, November 2016, Wiley

    Dr Ellis J Neufeld

  22. Skin testing, graded challenge, and desensitization to von Willebrand factor (VWF) products in type III von Willebrand disease (VWD)

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2016, Elsevier

    Dr Ellis J Neufeld

  23. Recognizing the need for personalization of haemophilia patient‐reported outcomes in the prophylaxis era

    Article • Haemophilia, August 2016, Wiley

    Dr Ellis J Neufeld

  24. Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label

    Article • Pediatric Blood & Cancer, May 2016, Wiley

    Dr Ellis J Neufeld

  25. Refractory Autoimmune Disease: An overview of when first-line therapy is not enough

    Article • Seminars in Hematology, April 2016, Elsevier

    Dr Ellis J Neufeld

  26. Unrelated Donor Marrow (BMT) or Cord Blood Transplantation (UCBT) for Thalassemia Major after Reduced Intensity Conditioning (URTH Trial Extension)

    Article • Biology of Blood and Marrow Transplantation, March 2016, Elsevier

    Dr Ellis J Neufeld

  27. A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand

    Article • Journal of Managed Care & Specialty Pharmacy, February 2016, Academy of Managed Care Pharmacy

    Dr Ellis J Neufeld

  28. Center-Based Quality Initiative Targets Youth Preparedness for Medical Independence:HEMO-Milestones Toolin a Comprehensive Hemophilia Clinic Setting

    Article • Pediatric Blood & Cancer, October 2015, Wiley

    Dr Ellis J Neufeld

  29. Erythrocyte pyruvate kinase deficiency: 2015 status report

    Article • American Journal of Hematology, August 2015, Wiley

    Dr Ellis J Neufeld

  30. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP

    Article • Blood, August 2015, American Society of Hematology

    Dr Ellis J Neufeld

  31. Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP)

    Article • Pediatric Blood & Cancer, July 2015, Wiley

    Dr Ellis J Neufeld

  32. Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results

    Article • Magnetic Resonance Imaging, July 2015, Elsevier

    Dr Ellis J Neufeld

  33. Safety update on the use of recombinant activated factor VII in approved indications

    Article • Blood Reviews, June 2015, Elsevier

    Dr Ellis J Neufeld

  34. Author's response: ‘Transition considerations for extended half‐life factor products’

    Article • Haemophilia, May 2015, Wiley

    Dr Ellis J Neufeld

  35. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia

    Article • British Journal of Haematology, April 2015, Wiley

    Dr Ellis J Neufeld

  36. Transition considerations for extended half‐life factor products

    Article • Haemophilia, April 2015, Wiley

    Dr Ellis J Neufeld

  37. Guidelines for the Standard Monitoring of Patients With Thalassemia

    Article • Journal of Pediatric Hematology/Oncology, April 2015, Wolters Kluwer Health

    Dr Ellis J Neufeld

  38. Skin Testing, Graded Challenge and Desensitization to Von Willebrand Factor (vWF) Products in Type III Von Willebrand Disease (VWD)

    Article • Journal of Allergy and Clinical Immunology, February 2015, Elsevier

    Dr Ellis J Neufeld

  39. Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System

    Article • The Journal of Pediatrics, January 2015, Elsevier

    Dr Ellis J Neufeld

  40. CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency

    Article • JIMD Reports, January 2015, Springer Science + Business Media

    Dr Ellis J Neufeld

  41. Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre‐based pharmacy hit the mark?

    Article • Haemophilia, October 2014, Wiley

    Dr Ellis J Neufeld

  42. Treatment and outcomes of immune cytopenias following solid organ transplant in children

    Article • Pediatric Blood & Cancer, October 2014, Wiley

    Dr Ellis J Neufeld

  43. Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)

    Article • Value in Health, September 2014, Elsevier

    Dr Ellis J Neufeld

  44. The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience

    Article • European Journal Of Haematology, April 2014, Wiley

    Dr Ellis J Neufeld

  45. MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

    Article • American Journal of Hematology, April 2014, Wiley

    Dr Ellis J Neufeld

  46. Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia

    Article • Quality of Life Research, March 2014, Springer Science + Business Media

    Dr Ellis J Neufeld

  47. R2 and R2* are equally effective in evaluating chronic response to iron chelation

    Article • American Journal of Hematology, March 2014, Wiley

    Dr Ellis J Neufeld

  48. Human T-cell lymphotropic virus type 1 infection among U.S. Thalassemia patients

    Article • Retrovirology, January 2014, Springer Science + Business Media

    Dr Ellis J Neufeld

  49. Rituximab for treatment of inhibitors in haemophilia A

    Article • Thrombosis and Haemostasis, January 2014, Thieme Publishing Group

    Dr Ellis J Neufeld

  50. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFVIIa doses across clinical...

    Article • Haemophilia, December 2013, Wiley

    Dr Ellis J Neufeld

  51. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major

    Article • British Journal of Haematology, November 2013, Wiley

    Dr Ellis J Neufeld

  52. Coagulopathy and Vascular Malformations

    Article • August 2013, Oxford University Press (OUP)

    Dr Ellis J Neufeld

  53. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

    Article • Transfusion, July 2013, Wiley

    Dr Ellis J Neufeld

  54. Pregnancy outcomes in women with thalassemia in North America and the United Kingdom

    Article • American Journal of Hematology, July 2013, Wiley

    Dr Ellis J Neufeld

  55. Human T Cell Lymphotropic Virus Type 1 Infection Among U.S. Thalassemia Patients

    Article • AIDS Research and Human Retroviruses, July 2013, Mary Ann Liebert Inc

    Dr Ellis J Neufeld

  56. Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion

    Article • Stem Cells, July 2013, Oxford University Press (OUP)

    Dr Ellis J Neufeld

  57. Novel dominant β-thalassemia: Hb Boston-Kuwait [Codon 139/140(+T)]

    Article • Pediatric Blood & Cancer, June 2013, Wiley

    Dr Ellis J Neufeld

  58. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension

    Article • Haematologica, April 2013, Ferrata Storti Foundation (Haematologica)

    Dr Ellis J Neufeld

  59. Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational ...

    Article • Haemophilia, April 2013, Wiley

    Dr Ellis J Neufeld

  60. Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)

    Article • Pediatric Blood & Cancer, January 2013, Wiley

    Dr Ellis J Neufeld

  61. To Treat or Not To Treat—From Guidelines to Individualized Patient Management

    Article • Seminars in Hematology, January 2013, Elsevier

    Dr Ellis J Neufeld

  62. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

    Article • Journal of Cardiovascular Magnetic Resonance, January 2013, Springer Science + Business Media

    Dr Ellis J Neufeld

  63. Increased leucocyte apoptosis in transfused β-thalassaemia patients

    Article • British Journal of Haematology, December 2012, Wiley

    Dr Ellis J Neufeld

  64. Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia

    Article • Value in Health, September 2012, Elsevier

    Dr Ellis J Neufeld

  65. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia

    Article • Blood, July 2012, American Society of Hematology

    Dr Ellis J Neufeld

  66. Inadequate Dietary Intake in Patients with Thalassemia

    Article • Journal of the Academy of Nutrition and Dietetics, July 2012, Elsevier

    Dr Ellis J Neufeld

  67. Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

    Article • Bone Marrow Transplantation, May 2012, Springer Science + Business Media

    Dr Ellis J Neufeld

  68. A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload

    Article • Blood, April 2012, American Society of Hematology

    Dr Ellis J Neufeld

  69. Does iron overload really matter in stem cell transplantation?

    Article • American Journal of Hematology, April 2012, Wiley

    Dr Ellis J Neufeld

  70. Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

    Article • Blood, March 2012, American Society of Hematology

    Dr Ellis J Neufeld

  71. Tracking the impact of the National Institutes of Health Clinical and Translational Science Awards on child health research: developing and evaluating a measurement strategy

    Article • Pediatric Research, February 2012, Nature

    Dr Ellis J Neufeld

  72. Beliefs about chelation among thalassemia patients

    Article • Health and Quality of Life Outcomes, January 2012, Springer Science + Business Media

    Dr Ellis J Neufeld

  73. Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects

    Article • American Journal of Hematology, December 2011, Wiley

    Dr Ellis J Neufeld

  74. Recognition and Management of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in the Emergency Department

    Article • Clinical Pediatric Emergency Medicine, September 2011, Elsevier

    Dr Ellis J Neufeld

  75. Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population

    Article • Pediatric Blood & Cancer, June 2011, Wiley

    Dr Ellis J Neufeld

  76. Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation

    Article • Pediatric Blood & Cancer, June 2011, Wiley

    Dr Ellis J Neufeld

  77. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia

    Article • Pediatric Blood & Cancer, June 2011, Wiley

    Dr Ellis J Neufeld

  78. Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, June 2011, Elsevier

    Dr Ellis J Neufeld

  79. Transition from pediatric to adult care for sickle cell disease: Results of a survey of pediatric providers

    Article • American Journal of Hematology, May 2011, Wiley

    Dr Ellis J Neufeld

  80. Risks Factors And Mortality Associated With Doppler-Defined-Pulmonary Hypertension In Thalassemia Major: A Report From The Thalassemia Clinical Research Network Longitudinal Cohort Study

    Article • May 2011, American Thoracic Society

    Dr Ellis J Neufeld

  81. Iron chelation adherence to deferoxamine and deferasirox in thalassemia

    Article • American Journal of Hematology, April 2011, Wiley

    Dr Ellis J Neufeld

  82. Renal dysfunction in patients with thalassaemia

    Article • British Journal of Haematology, February 2011, Wiley

    Dr Ellis J Neufeld

  83. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia

    Article • British Journal of Haematology, February 2011, Wiley

    Dr Ellis J Neufeld

  84. Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008)

    Article • Haemophilia, February 2011, Wiley

    Dr Ellis J Neufeld

  85. Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach

    Article • PEDIATRICS, February 2011, American Academy of Pediatrics (AAP)

    Dr Ellis J Neufeld

  86. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols

    Article • British Journal of Haematology, January 2011, Wiley

    Dr Ellis J Neufeld

  87. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload

    Article • Haematologica, December 2010, Ferrata Storti Foundation (Haematologica)

    Dr Ellis J Neufeld

  88. Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms

    Article • American Journal of Hematology, November 2010, Wiley

    Dr Ellis J Neufeld

  89. Relationship between Chronic Transfusion Therapy and Body Composition in Subjects with Thalassemia

    Article • The Journal of Pediatrics, October 2010, Elsevier

    Dr Ellis J Neufeld

  90. Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort

    Article • American Journal of Hematology, August 2010, Wiley

    Dr Ellis J Neufeld

  91. Oral chelation: Should it be used with young children?

    Article • Pediatric Blood & Cancer, August 2010, Wiley

    Dr Ellis J Neufeld

  92. Education and employment status of children and adults with thalassemia in North America

    Article • Pediatric Blood & Cancer, August 2010, Wiley

    Dr Ellis J Neufeld

  93. Preface to Cooley's Anemia: Ninth Symposium

    Article • Annals of the New York Academy of Sciences, August 2010, Wiley

    Dr Ellis J Neufeld

  94. Primary Care Clinicians’ Knowledge and Confidence About Newborn Screening for Sickle Cell Disease: Randomized Assessment of Educational Strategies

    Article • Journal of the National Medical Association, August 2010, Elsevier

    Dr Ellis J Neufeld

  95. Observational Cohort Study of Pediatric Inpatients With Central Venous Catheters at “Intermediate Risk” of Thrombosis and Eligible for Anticoagulant Prophylaxis

    Article • Journal of Pediatric Oncology Nursing, July 2010, SAGE Publications

    Dr Ellis J Neufeld

  96. PSY45 IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES: OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHI...

    Article • Value in Health, May 2010, Elsevier

    Dr Ellis J Neufeld

  97. PSY46 EFFECT OF ACUTE BLEEDING EPISODES ON QUALITY OF LIFE (QOL) IN PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR FAMILIES: OBSERVATIONS OF BLEED VS. NON-BLEED DAY QOL FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE) AND ...

    Article • Value in Health, May 2010, Elsevier

    Dr Ellis J Neufeld

  98. Erratum: “Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission” by Sobota et al.,Am J Hematol2010 DOI number 21565

    Article • American Journal of Hematology, May 2010, Wiley

    Dr Ellis J Neufeld

  99. Genetic studies in pediatric ITP: outlook, feasibility, and requirements

    Article • Annals of Hematology, March 2010, Springer Science + Business Media

    Dr Ellis J Neufeld

  100. Future research in ITP: an ICIS consensus

    Article • Annals of Hematology, March 2010, Springer Science + Business Media

    Dr Ellis J Neufeld

  101. Infantile Myofibroma or Lymphatic Malformation

    Article • Journal of Craniofacial Surgery, March 2010, Wolters Kluwer Health

    Dr Ellis J Neufeld

  102. Pain as an emergent issue in thalassemia

    Article • American Journal of Hematology, January 2010, Wiley

    Dr Ellis J Neufeld

  103. Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter

    Article • Clinical Immunology, December 2009, Elsevier

    Dr Ellis J Neufeld

  104. Thiamine-Responsive Megaloblastic Anemia: Identification of Novel Compound Heterozygotes and Mutation Update

    Article • The Journal of Pediatrics, December 2009, Elsevier

    Dr Ellis J Neufeld

  105. Hemoglobin H-constant spring in North America: An alpha thalassemia with frequent complications

    Article • American Journal of Hematology, November 2009, Wiley

    Dr Ellis J Neufeld

  106. Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations

    Article • Pediatric Blood & Cancer, September 2009, Wiley

    Dr Ellis J Neufeld

  107. Remission from transfusion-dependence in a patient with congenital dyserythropoietic anemia (CDA) and increased intensity of iron chelation

    Article • Pediatric Blood & Cancer, July 2009, Wiley

    Dr Ellis J Neufeld

  108. Compliance with immunizations in splenectomized individuals with hereditary spherocytosis

    Article • Pediatric Blood & Cancer, July 2009, Wiley

    Dr Ellis J Neufeld

  109. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion

    Article • Journal of Thoracic and Cardiovascular Surgery, April 2009, Elsevier

    Dr Ellis J Neufeld

  110. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab

    Article • Pediatric Blood & Cancer, February 2009, Wiley

    Dr Ellis J Neufeld

  111. Response to mercaptopurine for refractory autoimmune cytopenias in children

    Article • Pediatric Blood & Cancer, January 2009, Wiley

    Dr Ellis J Neufeld

  112. Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission

    Article • American Journal of Hematology, January 2009, Wiley

    Dr Ellis J Neufeld

  113. Compliance with Immunizations in Splenectomized Individuals: A Study of the Splenectomized Hereditary Spherocytosis Population

    Article • Blood, November 2008, American Society of Hematology

    Dr Ellis J Neufeld

  114. Female monozygotic twins discordant for hemophilia A due to nonrandom X-chromosome inactivation

    Article • American Journal of Hematology, October 2008, Wiley

    Dr Ellis J Neufeld

  115. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias

    Article • American Journal of Hematology, October 2008, Wiley

    Dr Ellis J Neufeld

  116. The Incidence and Implications of Anti-Heparin-Platelet Factor 4 Antibody Formation in a Pediatric Cardiac Surgical Population

    Article • Anesthesia & Analgesia, August 2008, Wolters Kluwer Health

    Dr Ellis J Neufeld

  117. Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

    Article • European Journal Of Haematology, December 2007, Wiley

    Dr Gian Luca Forni, Dr Ellis J Neufeld

  118. Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children

    Article • The Journal of Pediatrics, April 2007, Elsevier

    Dr Ellis J Neufeld

  119. Clinical Effects and Safety of Rituximab for Treatment of Refractory Pediatric Autoimmune Diseases

    Article • The Journal of Pediatrics, April 2007, Elsevier

    Dr Ellis J Neufeld

  120. Successful Use of Bivalirudin for Cardiac Transplantation in a Child With Heparin-induced Thrombocytopenia

    Article • The Journal of Heart and Lung Transplantation, November 2006, Elsevier

    Dr Ellis J Neufeld

  121. Urinary hepcidin in congenital chronic anemias

    Article • Pediatric Blood & Cancer, January 2006, Wiley

    Dr Ellis J Neufeld

  122. Targeted ITP strategies: Do they elucidate the biology of ITP and related disorders?

    Article • Pediatric Blood & Cancer, January 2006, Wiley

    Dr Ellis J Neufeld

  123. Relationship of Transfusion and Iron-Related Complications to Cost of Care in Thalassemia.

    Article • Blood, November 2005, American Society of Hematology

    Dr Ellis J Neufeld

  124. Hemoglobin Jamaica Plain — A Sickling Hemoglobin with Reduced Oxygen Affinity

    Article • New England Journal of Medicine, October 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Ellis J Neufeld

  125. Myocardial iron measurements by MRI: getting to the heart of the matter

    Article • Blood, March 2004, American Society of Hematology

    Dr Ellis J Neufeld

  126. Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2

    Article • Molecular Genetics and Metabolism, September 2003, Elsevier

    Dr Ellis J Neufeld

  127. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

    Article • The Lancet, May 2003, Elsevier

    Dr Ellis J Neufeld

  128. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A

    Article • Intensive Care Medicine, April 2003, Springer Science + Business Media

    Dr Ellis J Neufeld

  129. Thiamine-responsive megaloblastic anemia (TRMA) syndrome: consequences of defective high-affinity thiamine transport

    Article • January 2003, Springer Science + Business Media

    Dr Ellis J Neufeld

  130. Time course of early induction of intracellular adhesion molecule-1 messenger RNA during reperfusion, following cardiopulmonary bypass with hypothermic circulatory arrest in lambs

    Article • Pediatric Critical Care Medicine, January 2003, Wolters Kluwer Health

    Dr Ellis J Neufeld

  131. Chronic Disseminated Intravascular Coagulation and Childhood-Onset Skin Necrosis Resulting From Homozygosity for a Protein C Gla Domain Mutation, Arg15Trp

    Article • Journal of Pediatric Hematology/Oncology, November 2002, Wolters Kluwer Health

    Dr Ellis J Neufeld

  132. Starting out right: Kozak sequences and clots

    Article • Blood, August 2002, American Society of Hematology

    Dr Ellis J Neufeld

  133. Risk factors for thromboembolism in teens: when should I test?

    Article • Current Opinion in Pediatrics, August 2002, Wolters Kluwer Health

    Dr Ellis J Neufeld

  134. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2002, Elsevier

    Dr Ellis J Neufeld

  135. Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

    Article • The Annals of Thoracic Surgery, January 2002, Elsevier

    Dr Ellis J Neufeld

  136. Coagulation Abnormalities in Pediatric and Adult Patients After Sclerotherapy or Embolization of Vascular Anomalies

    Article • American Journal of Roentgenology, December 2001, American Roentgen Ray Society

    Dr Ellis J Neufeld

  137. Inflammatory Bowel Disease Associated With Immune Thrombocytopenic Purpura in Children

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 2001, Wolters Kluwer Health

    Dr Ellis J Neufeld

  138. Characterization of a Murine High-Affinity Thiamine Transporter, Slc19a2

    Article • Molecular Genetics and Metabolism, September 2001, Elsevier

    Dr Ellis J Neufeld

  139. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome

    Article • British Journal of Haematology, May 2001, Wiley

    Dr Ellis J Neufeld

  140. Thiamine-Responsive Megaloblastic Anemia Syndrome: A Disorder of High-Affinity Thiamine Transport

    Article • Blood Cells Molecules and Diseases, January 2001, Elsevier

    Dr Ellis J Neufeld

  141. 3714 SOLITARY COLONIC ULCER ASSOCIATED WITH COAGULATION FACTOR DEFICIENCY.

    Article • Gastrointestinal Endoscopy, April 2000, Elsevier

    Dr Ellis J Neufeld

  142. Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population

    Article • Clinical Biochemistry, March 2000, Elsevier

    Dr Ellis J Neufeld

  143. Homeoproteins CDP and SATB1 Interact: Potential for Tissue-Specific Regulation

    Article • Molecular and Cellular Biology, July 1999, ASM Journals

    Dr Ellis J Neufeld

  144. Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts

    Article • Journal of Clinical Investigation, March 1999, American Society for Clinical Investigation

    Dr Ellis J Neufeld

  145. Cux/CDP Homeoprotein Is a Component of NF-μNR and Represses the Immunoglobulin Heavy Chain Intronic Enhancer by Antagonizing the Bright Transcription Activator

    Article • Molecular and Cellular Biology, January 1999, ASM Journals

    Dr Ellis J Neufeld

  146. TIME COURSE OF EARLY ICAM-1 mRNA INDUCTION IN LUNG AND VENTRICLE FOLLOWING CARDIOPULMONARY BYPASS IN LAMBS

    Article • Critical Care Medicine, January 1999, Wolters Kluwer Health

    Dr Ellis J Neufeld

  147. HEMOPHILIA

    Article • Hematology/Oncology Clinics of North America, December 1998, Elsevier

    Dr Ellis J Neufeld

  148. UPDATE ON GENETIC RISK FACTORS FOR THROMBOSIS AND ATHEROSCLEROTIC VASCULAR DISEASE

    Article • Hematology/Oncology Clinics of North America, December 1998, Elsevier

    Dr Ellis J Neufeld

  149. Prevalence of factor V Leiden in a population of patients with congenital heart disease

    Article • Canadian Journal of Anesthesia/Journal canadien d anesthésie, December 1998, Springer Science + Business Media

    Dr Ellis J Neufeld

  150. PREFACE

    Article • Hematology/Oncology Clinics of North America, December 1998, Elsevier

    Dr Ellis J Neufeld

  151. Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity

    Article • Human Genetics, November 1998, Springer Science + Business Media

    Dr Ellis J Neufeld

  152. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease

    Article • The Journal of Pediatrics, August 1998, Elsevier

    Dr Ellis J Neufeld

  153. Hair Defects and Pup Loss in Mice with Targeted Deletion of the First Cut Repeat Domain of theCux/CDPHomeoprotein Gene

    Article • Developmental Biology, August 1998, Elsevier

    Dr Ellis J Neufeld

  154. Localization of the Gene for Thiamine-Responsive Megaloblastic Anemia Syndrome, on the Long Arm of Chromosome 1, by Homozygosity Mapping

    Article • The American Journal of Human Genetics, December 1997, Elsevier

    Dr Ellis J Neufeld

  155. CASP, a novel, highly conserved alternative-splicing product of the CDP/cut/cux gene, lacks cut-repeat and homeo DNA-binding domains, and interacts with full-length CDP in vitro

    Article • Gene, September 1997, Elsevier

    Dr Ellis J Neufeld

  156. Combined Schedule of Pneumococcal Conjugate Vaccine Followed by Pneumococcal Polysaccharide Vaccine in Patients With Sickle Cell Disease. • 779

    Article • Pediatric Research, April 1997, Nature

    Dr Ellis J Neufeld

  157. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts

    Article • The Annals of Thoracic Surgery, November 1996, Elsevier

    Dr Ellis J Neufeld

  158. Hypoxia enhances inflammatory regulation of E-selectin through a cAMP-dependent pathway

    Article • Journal of the American College of Cardiology, February 1996, Elsevier

    Dr Ellis J Neufeld

  159. ARMS test for diagnosis of factor V Leiden mutation, a common cause of inherited thrombotic tendency

    Article • Journal of Clinical Laboratory Analysis, January 1996, Wiley

    Dr Ellis J Neufeld

  160. P-selectin expression in myocardium of children undergoing cardiopulmonary bypass

    Article • Journal of Thoracic and Cardiovascular Surgery, October 1995, Elsevier

    Dr Ellis J Neufeld

  161. Severe haemophilia A in a female resulting from two de novo factor VIII mutations

    Article • British Journal of Haematology, August 1995, Wiley

    Dr Ellis J Neufeld

  162. Repressor Activity of CCAAT Displacement Protein in HL-60 Myeloid Leukemia Cells

    Article • Journal of Biological Chemistry, May 1995, Elsevier

    Dr Ellis J Neufeld

  163. Inherited dyslipidemias in childhood

    Article • Current Opinion in Pediatrics, December 1993, Wolters Kluwer Health

    Dr Ellis J Neufeld

  164. Volume 187, Number 2 (1992), in the article "Sequence-Specific Binding of HMG-I(Y) to the Proximal Promoter of the gp91-phox Gene," by David G. Skalnik and Ellis J. Neufeld, pages 563-569

    Article • Biochemical and Biophysical Research Communications, January 1993, Elsevier

    Dr Ellis J Neufeld

  165. Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox gene

    Article • Biochemical and Biophysical Research Communications, September 1992, Elsevier

    Dr Ellis J Neufeld

  166. Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut

    Article • Nature Genetics, April 1992, Nature

    Dr Ellis J Neufeld

  167. Neufeld Replies

    Article • The Gerontologist, June 1991, Oxford University Press (OUP)

    Dr Ellis J Neufeld

  168. Phosphoinositide turnover provides a link in stimulus—response coupling

    Article • Trends in Biochemical Sciences, April 1985, Elsevier

    Dr Ellis J Neufeld

  169. Production of phosphoinositide-derived messengers

    Article • Cell, July 1984, Elsevier

    Dr Ellis J Neufeld

  170. A mutant fibroblast cell line defective in glycoprotein synthesis due to a deficiency of glucosamine phosphate acetyltransferase

    Article • Archives of Biochemistry and Biophysics, June 1978, Elsevier

    Dr Ellis J Neufeld